Apostolou, Effie
- Weill Cornell Medicine · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11,910
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$880K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#11,910
By linked amount among FY2023 PIs
Earliest Year Loaded
2016
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Apostolou, Effie as a PI. Multi-PI records show the full award amount for context.
- 5R01GM138635-04R01Contact PIOrganizational principles and functional role of 3D enhancer hubs in cell fate decisionsWeill Cornell Medicine · Internal Medicine (NIH department code)$474.2Kaward amount
- 1R01CA283327-01R01Contact PICharacterizing stem cell-like B cell subpopulations and dissecting their role in tumorigenesisWeill Cornell Medicine · Internal Medicine (NIH department code)$405.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Apostolou, Effie as a PI.
FY2023 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardWeill Cornell Medicine
- 2016$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016$2M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #1853
- 2016Entered Top 25% NationallyRanked #1853
- 2016Entered Top 10% NationallyRanked #1853
- 2021R01 Grant Holder